TECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE
|
|
|
- Sydney Richards
- 5 years ago
- Views:
Transcription
1 TECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE
2 Who we are Our experience, your support. We are one of the leading companies specialized in research, development and manufacturing of pharmaceutical products for third parties. We have a history of over 35 years offering effective solutions to our customers through science, technology and a team of highly trained professionals. Novocap INNOVATION EXPERIENCE SERVICE HUMAN QUALITY We started our activities in Buenos Aires, Argentina in 1973 as Diffucap Eurand S.A. and since our establishment we have specialized in the development and manufacturing of value-added pharmaceutical products enabled by the use of oral modified-release technologies. Besides technology, what makes us special is our people. All of our projects are handled by collaborative teams integrated by experienced professionals driven by a shared vision and a culture of customer service.
3 What we do Our services, your solution. We serve our customers. We collaborate throughout all the stages of development, from the idea to the finished product, including formulation development, clinical research and industrial-scale production under GMP standards. We offer our experience and ability to solve the most complex challenges. Comprehensive service DEVELOPMENT RESEARCH PRODUCTION Development: Our technologies allow us to create high value-added pharmaceutical products: Extended Release Increased Solubility / Absorption Taste Masking Enteric / Colonic Release Combination of Incompatible / Unstable Drugs Clinical Research: We specialize in pharmacokinetic studies. We have broad experience in comparative bioavailability and bioequivalence studies. Production: We have a unique industrial plant in Latin America. We manufacture over 300 million doses (capsules, tablets, microcapsules and pellets) per year.
4 We innovate Our innovation, your competitive advantage. We form interdisciplinary teams, which combine technology, science and creativity, integrating specialized know-how and the ability to transform ideas into effective solutions. TECHNOLOGY SCIENCE CREATIVITY QUALITY Quality Assurance Qualifications Validations Quality Control INDUSTRIAL PLANT Production Health and Safety Engineering REGULATORY AFFAIRS Registration DEVELOPMENT Pharmaceutical Analytical TEAM CUSTOMER SERVICE Business Development Customer Management INTELLECTUAL PROPERTY Trademarks Patents CLINICAL STUDIES Bioavailability Bioequivalence
5 We are chosen Working together with our customers, we create high value-added products. We work openly and in close collaboration with our customers in order to create products with significant advantages, which add value to your business. We build long lasting relationships based on trust, professionalism and accountability. Using our technology, we have developed over 100 products, which are marketed by our customers worldwide. STRENGTH PROFESSIONALISM TRUST ACCOUNTABILITY
6 We move forward Building the future together. We are at the forefront of technology. Our mission is to provide reliable solutions and tailored to the needs of our customers, today and tomorrow. The innovative culture and work environment in Novocap motivates us to continue learning and developing new skills. In order to enhance our knowledge and generate new solutions, we actively look for alliances with other pharmaceutical companies, universities and research centers. Trust us. Let us show you that we are the strategic partner your business needs. Yesterday Regular tablets and capsules. Today Modified release microgranules. Taste-masked microcapsules. Formulations of increased solubility. Formulations of incompatible active principles. Tomorrow Increased oral absorption of low-permeability molecules. Alternative routes of administration of biotech products.
7 w w w.novoc ap.com Novocap S.A. Industrial Plant: Administration: Tel (54-11) Ing. Torcuato Di Tella 968 Ing. Torcuato Di Tella 911 info@novocap.com (B1868BIB) Avellaneda (B1868BIA) Avellaneda Buenos Aires, Argentina Buenos Aires, Argentina
peace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
Section heading. Strapline sub-heading
Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide
Leader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.
API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our
Glatt Technology Center
Glatt Technology Center Pharmaceutical Development Formulation Development Process Development Scale-Up Contract Manufacturing Equipment Design Technology Transfer Full Service Development. Scale-Up. Production.
TRIPS and Access to Medicines. WR Briefing
TRIPS and Access to Medicines WR Briefing Outline What is TRIPS How does it affect access to medicines What are the TRIPS flexibilities? What are extra-trips provisions? How do the extra-trips provisions
Glatt Technology Center
Glatt Technology Center Pharmaceutical Development Formulation Development Process Development Scale-Up Contract Manufacturing Equipment Design Technology Transfer We set the standards Contract manufacturing
Quality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
Pharmaceutical Manufacturing and Engineering Catalog Excerpt
Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
Pharmaceutical Process Development
Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage
JUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014
MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014 A*STAR-HELLMA PARTNERSHIP TO INNOVATE MANUFACTURING PROCESSES Hellma Analytics, a leading company in optics analysis technologies, partners with A*STAR to
Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
THE AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION RECOMMENDATIONS REGARDING QUALIFICATIONS FOR
THE AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION RECOMMENDATIONS REGARDING QUALIFICATIONS FOR THE NEXT DIRECTOR AND DEPUTY DIRECTOR OF THE U.S. PATENT AND TRADEMARK OFFICE Revised and approved, AIPLA
Find and analyse the most relevant patents for your research
Derwent Innovation Find and analyse the most relevant patents for your research Powering the innovation lifecycle from idea to commercialisation The pace of technology change is unprecedented with new
Globalisation increasingly affects how companies in OECD countries
ISBN 978-92-64-04767-9 Open Innovation in Global Networks OECD 2008 Executive Summary Globalisation increasingly affects how companies in OECD countries operate, compete and innovate, both at home and
WHO WE ARE MISSION STATEMENT
WHO WE ARE Parker Life Sciences offers reliable fluidic and motion control products, MetaModules, and systems to customers in life sciences and in analytical instrumentation markets. As part of Parker
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
Challenges of Implementation of ICH Q 8
Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated
Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma
Brazilian industry s activities for international convergence Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Mission Congregate companies, institutes and association
Pharmaceutical Products and Services
Pharmaceutical Products and Services Johnson Matthey (JM) combines specialist expertise and a 200-year heritage, to deliver a collaborative service offering focused on strengthening your products to ensure
Dynamics of National Systems of Innovation in Developing Countries and Transition Economies. Jean-Luc Bernard UNIDO Representative in Iran
Dynamics of National Systems of Innovation in Developing Countries and Transition Economies Jean-Luc Bernard UNIDO Representative in Iran NSI Definition Innovation can be defined as. the network of institutions
Intellectual property governance and strategic value creation:
Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita
HIV and co-infection medicines
IP and regulatory barriers in LMICs HIV and co-infection medicines APACC, 2018 Hongkong, June 2018 Monopolies linked to Prices Monopoly No monopoly One supplier Multiple suppliers No competition Competition
Oil & Gas. GST Engineering
Oil & Gas Life Sciences Special Technologies index Who we are Our Vision Our Mission Our Values Our Organization What we do Sectors Disciplines Services Consulting Services EPC Services How we do it Technological
University joins Industry: IP Department. Georgina Marjanet Ferrer International, SA
University joins Industry: IP Department Georgina Marjanet Ferrer International, SA Topics Ø What is IP? Ø Importance of IP in the pharmaceutical industry Ø IP Department: tasks and responsibilities Ø
Industry Expertise: P R O D U C E R S P R O D U C E R S Bursting With Flavors Since 1981 Bursting Flavors
P R O D U C E R S BurstingwithFlavors Welcome to Flavor Producers! We have been delivering the highest quality custom flavors with the most attentive service to clients across industries since 1981. We
GSK s Development of Novel Oral Delivery Technologies Perspectives
GSK s Development of Novel Oral Delivery Technologies Perspectives Mark Wilson Director, PTS, R&D GlaxoSmithKline Pharmaceuticals GSK Established a Technology Incubator To Develop Drug Delivery Systems
Health Care Ltd 3M United Kingdom PLC Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company s customers know they can rely on 3M to help make
Implementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
WHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.
WHITE PAPER FACILITY FOCUS: GMP Facility Modernization By: David M. Marks, P.E. July 2017 Introduction In recent years, intensified industry competition and cost pressures have renewed interest in modernizing
New York Bar admission (or eligibility to obtain admission promptly) is required.
Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are
ICH Q8 / ICH Q11 Training Course
ICH Q8 / ICH Q11 Training Course From QbD to Process Validation Speakers: Dr Thomas Hille LTS Lohmann Therapie- Systeme AG Dr Øyvind Holte Norwegian Medicines Agency, EDQM PAT working party/ EMA PAT team
Bosch Packaging Academy Seminars & Workshops
Bosch Packaging Academy Seminars & Workshops 2018 www.boschpackaging.com/academy All Bosch Packaging Academy Seminars & Workshops at a glance The Bosch Packaging Academy team is proud to present the new
Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
VACCINE MANUFACTURING IN DEVELOPING COUNTRIES
VACCINE MANUFACTURING IN DEVELOPING COUNTRIES PERSPECTIVES ON APPROACHES TO TAKE, AND FACTORS TO CONSIDER, TOWARDS SUSTAINABLE MANUFACTURING CAPABILITY Martin Nicholson Pharmaceutical Expert, Dept. of
Science Integration Fellowship: California Ocean Science Trust & Humboldt State University
Science Integration Fellowship: California Ocean Science Trust & Humboldt State University SYNOPSIS California Ocean Science Trust (www.oceansciencetrust.org) and Humboldt State University (HSU) are pleased
Emerging Sources Citation Index. More research and trends from emerging and less-established sources. Romania Case Study
Emerging Sources Citation Index More research and trends from emerging and less-established sources. Romania Case Study Web of Science Trust the difference 2 Emerging Sources Cita tion Index 46% OF JOURNALS
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
Media & Entertainment. Shaping tomorrow with you
Media & Entertainment Shaping tomorrow with you Welcome to a world of Connected Media & Entertainment Connected Digital Media Experience The world is experiencing a digital revolution. The Internet of
Research Patents in Biotech SMEs
Research Patents in Biotech SMEs Doorways, Obstacles, Fortifications & Bridges Neil Thomas PhD Director of Intellectual Property, Genetrix Group, Madrid, Spain. Agenda 1. Introduction to Genetrix Definition
Purpose of the summary
Summary of Expertise, Experience, and Affiliations and Interests Scientific Advisory Committee on Sciences and Clinical Pharmacology (SAC-PSCP) Purpose of the summary The following table summarizes the
UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS
UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure,
Intellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
Study of Comparative Advantages of Chinese and Indian Pharmaceutical Industries under Globalization
MANAGEMENT SCIENCE AND ENGINEERING Vol. 4, No. 4, 2010, pp. 82-86 www.cscanada.org ISSN 1913-0341 [Print] ISSN 1913-035X [Online] www.cscanada.net Study of Comparative Advantages of Chinese and Indian
SCIENTIFIC INTEGRITY
AFFORDABLE, WORLD-CLASS QUALITY PRODUCTS GROUNDED IN SCIENTIFIC INTEGRITY Our goal is to grow a global presence in prescription brands, generics, over the counter (OTC), and private label products through
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) The Post-Graduates will acquire adequate scientific information regarding basic principles of Pharmaceutics including Cosmetology, Specialized drug
Intelligent Textiles Limited. John Hopkins October 2012
Intelligent Textiles Limited John Hopkins October 2012 Sponsored by the UK government Department for Business Innovation & Skills (BIS), the Technology Strategy Board is a business-led executive nondepartmental
LIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment
Presenter: Randall Sunberg Morgan Lewis May 16, 2008 In cooper Biography Randall Sunberg partner Morgan Lewis, Princeton Phone: 609.919.6606 Randall B. Sunberg is a partner in Morgan Lewis's Business and
The Sherwin-Williams Company
The Sherwin-Williams Company "What is Worth Doing is Worth Doing Well." Founded in 1866 in Cleveland, Ohio #1 coatings company in the Americas #3 coatings company worldwide Over 40,000 employees worldwide
What could be driving the Lab of the future and is the Smart Lab really a thing?
What could be driving the Lab of the future and is the Smart Lab really a thing? Paul Kendall Festo MedLab 28 February 2018 ELRIG Robotics & Automation, Esslingen near Stuttgart. 1 What s in store? Position
Making lives better every day. This is UCB
Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living
Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036
2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop
HARNESSING TECHNOLOGY
HARNESSING TECHNOLOGY TO TRANSFORM PUBLIC SERVICE DELIVERY AND OUTCOMES ACCENTURE PUBLIC SERVICE TECHNOLOGY CONSULTING Remember when public service organizations viewed IT as a cost center separate from
Overview on Medicines Regulation: regulatory cooperation and harmonization in focus
Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Dr Samvel Azatyan Manager, Medicines Regulatory Support Programme Quality Assurance and Safety: Medicines Essential Medicines
Intellectual Property
Intellectual Property 1 Overview In a progressively uncertain economy, counterfeit products are becoming more prevalent particularly in Vietnam. Therefore, companies should be increasingly vigilant in
Presentation. March 2007
Presentation March 2007 1 Corporate Overview 2 Corporate Overview Leading provider of research-driven packaging solutions solely-focused on pharmaceutical industry Founded in 1994 and based in Pune, India
The Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process
1780 Wehrle Drive Suite 110 Buffalo, New York 14221 716.633.3463 cognigencorp.com The Transition to Model-Based Drug Development Phase 1: Formalizing the Pharmacometric Process By Thaddeus H. Grasela,
A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total
SCIENCE + BEAUTY Technical Expertise for the Beauty Industry 6 pages total We can help you with a single scientific requirement Or take a full 360 o approach An Experienced Partner Schoon Scientific is
Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D08 - HAI Europe Newsletter (EN)... 7 D01 - HAI Europe leaflet (EN)... 7 D02 - Briefing Papers and statements
ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020
ADVANCING KNOWLEDGE FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020 Social sciences and humanities research addresses critical
INTELLECTUAL PROPERTY STRATEGIC CONSULTING
INTELLECTUAL PROPERTY STRATEGIC CONSULTING The right protection can get you anywhere The human mind is capable of generating ideas that can change the destiny of a company, forever marking its course of
FOCUSED INNOVATIONS IN LIFE SCIENCES
FOCUSED INNOVATIONS IN LIFE SCIENCES INNOVATIONS IN LIFE SCIENCES Gore first entered the Life Sciences industry in the mid-1970s with a life-saving blood vessel replacement engineered to work in harmony
Midwest Regional Forum. Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs
Midwest Regional Forum Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs Tuesday, October 23, 2018 Loews Chicago O Hare Hotel Rosemont, IL Meeting Co-chairs: Sarah Demmon, Eli
Appendix 2 Statoil: About our brand. 14 pages
Appendix 2 Statoil: About our brand 14 pages APPENDIX 2 - Page 1 of 14 Statoil Guidelines (October 2010) APPENDIX 2 - Page 2 of 14 Our brand is our logo, right? And correct use of colours? Yes. But it
1. Protecting the work and expressing the potential of our clients' companies
Turin, December, 2012 PRESS FOLDER 1. Protecting the work and expressing the potential of our clients' companies 2. Over a century of solid experience and steady growth 3. A network of excellence 4. Leadership
ACCELERATING THE FUTURE OF SEMICONDUCTORS
ACCELERATING THE FUTURE OF SEMICONDUCTORS 14 PRODUCTION FACILITIES 7R&D FACILITIES 10+ COUNTRIES VERSUM MATERIALS BY THE NUMBERS* *Fiscal year ending September 30, 2018. 250+ CUSTOMERS CORE INDUSTRIES
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
Intellectual Property Policy. DNDi POLICIES
Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments
(Fig.) JPMA Industry Vision 2025
2. JPMA Industry Vision 2025 Against the background of the changing environment surrounding the pharmaceutical industry and the future predictions *1, we prepared JPMA Industry Vision 2025 Bringing Innovation
With you from pit to port. Mining & Metallurgy
With you from pit to port Mining & Metallurgy A different perspective on mining Smart solutions, extensive capabilities, and a long-term vision With over 65 years of experience in mining and metallurgy,
Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
CORPORATE OVERVIEW BREAKING THERMAL BARRIERS
CORPORATE OVERVIEW BREAKING THERMAL BARRIERS Breaking Thermal Barriers Higher performance and greater electronic densities don t have to mean higher temperatures when you have Thermacore technologies and
Draft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter
Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Pharma Boardroom An Exclusive Interview with Jonathan Hunt CEO, Syngene International, India. Jonathan Hunt, CEO of Syngene International,
Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO
Brief to the Senate Standing Committee on Social Affairs, Science and Technology Dr. Eliot A. Phillipson President and CEO June 14, 2010 Table of Contents Role of the Canada Foundation for Innovation (CFI)...1
Intellectual Property, Vaccine Production and Technology Transfer
Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations
Intellectual Property Management Medicines for Malaria Venture. Life Sciences Symposium WIPO 15 December 2008
Intellectual Property Management Medicines for Malaria Venture Life Sciences Symposium WIPO 15 December 2008 1 Structure of the presentation 1. MMV at a glance - PPP model 2. MMV and Intellectual Property
THIS IS RESEARCH. THIS IS AUBURN RESEARCH.
2013 ANNUAL REPORT OF RESEARCH ACTIVITY THIS IS RESEARCH. THIS IS AUBURN RESEARCH. Rising to the Challenge GROUND BREAKING ELIZABETH LIPKE S CHEMICAL ENGINEERING LAB AT AUBURN is growing human heart cells
THE DRIVING FORCE BEHIND THE FOURTH INDUSTRIAL REVOLUTION
TECNALIA INDUSTRY AND TRANSPORT INDUSTRY 4.0 THE DRIVING FORCE BEHIND THE FOURTH INDUSTRIAL REVOLUTION www.tecnalia.com INDUSTRY 4.0 A SMART SOLUTION THE DRIVING FORCE BEHINDTHE FOURTH INDUSTRIAL REVOLUTION
Connecting Science and Society. NWO strategy
Connecting Science and Society NWO strategy 2019-2022 Connecting Science and Society This strategic plan describes NWO's course for the period 2019 to 2022. In this plan, NWO emphasises its connecting
MENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS
Hosted by : INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris MENTORS REGULATORY AFFAIRS Christophe Amiel is heading the design and operational implementation of international regulatory strategies as Senior
Facing the Future: Additive Manufacturing SECOND ROUND. Call for Partners: Consortium Study. Our partners:
Facing the Future: Additive Manufacturing SECOND ROUND Call for Partners: Consortium Study Our partners: Additive Manufacturing: The New Industrial Revolution? Motivation Costs for additive manufactured
Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
Engr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD)
13% 13% 74% Engr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD) Introduction on IPOPhl s Patent System Innovation Support Strategies TOPICS Patent Mapping/Analytics
Symposium on Continuous Manufacturing of Pharmaceuticals Notes
1 2012 11 13 Symposium on Continuous Manufacturing of Pharmaceuticals Notes These are notes from the first open meeting regarding Novartis- MIT Center for Continuous Manufacturing (CCM). The meeting is
NATIONAL DESIGN POLICY. Approved by Government of India
NATIONAL DESIGN POLICY Approved by Government of India NATIONAL DESIGN POLICY 1. INTRODUCTION 2. DESIGNED IN INDIA, MADE FOR THE WORLD 3. DESIGN FRAMEWORK 4. DESIGN INNOVATION 5. QUALITY DESIGN EDUCATION
Be prepared! Upgrade for mission success.
Be prepared! Upgrade for mission success. Welcome to RUAG Defence As a technology partner, RUAG Defence helps armed forces carry out their operations successfully. With our services, we help to ensure
Lupin Limited Annual Results FY12. Investor Presentation May being
Lupin Limited Annual Results FY12 Investor Presentation May 2012 Vision: To be an innovation led transnational company Journey over the last decade 5th largest generics player in US Gross Revenues INR
CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS
CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS INDEPENDENT THINKING. COLLECTIVE EXCELLENCE. Your intellectual property assets are of great value to you. To help you to secure, protect
FROM THE GLASS TUBE TO OPTIMUM SYSTEM PACKAGING
Packaging from aus tubing Röhrenglas glass isoverpackungen Precious contents perfectly packaged FROM THE GLASS TUBE TO OPTIMUM SYSTEM PACKAGING www.iso-online.de Made in Germany Contents Philosophy Production
Supporting Industrial Property for Shared Prosperity. The Japan Funds-in-Trust for Industrial Property in Asia and the Pacific
Supporting Industrial Property for Shared Prosperity The Japan Funds-in-Trust for Industrial Property in Asia and the Pacific Intellectual property (IP) is a great force for human progress. A well-functioning
COURSE 2. Mechanical Engineering at MIT
COURSE 2 Mechanical Engineering at MIT The Department of Mechanical Engineering MechE embodies the Massachusetts Institute of Technology s motto mens et manus, mind and hand as well as heart by combining
MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2016 FINANCIAL RESULTS AND OPERATIONAL PROGRESS
REGULATED INFORMATION MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2016 FINANCIAL RESULTS AND OPERATIONAL PROGRESS Liège, Belgium 1 September 2016, 07h30 Mithra Pharmaceuticals, a leader in Women s
SMART HYDRAULICS MINING & CONSTRUCTION AGRICULTURE & MAINTENANCE LOAD HANDLING FORESTRY HOISTING RECYCLING DEFENSE INDUSTRIAL ENERGY
Manufacturing tomorrow s intelligent hydraulic systems by collaborating and empowering industries today. SMART HYDRAULICS MINING & CONSTRUCTION AGRICULTURE & MAINTENANCE LOAD HANDLING FORESTRY HOISTING
AAL2BUSINESS Towards successful commercialization of AAL solutions
AAL2BUSINESS Towards successful commercialization of AAL solutions AGENDA 1. AAL2Business support action Introduction, objectives and big picture of services? (10 min) 2. Better commercial success with